Treatment continuation in patients receiving biological agents or conventional DMARD therapy

Objective: To compare drug continuation rates in patients with rheumatoid arthritis who start on a biological agent and in a control group of patients with a change in disease modifying antirheumatic drug (DMARD) treatment after previous DMARD failure. Methods: Patients with rheumatoid arthritis enr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Zink, A, Listing, J, Kary, S, Ramlau, P, Stoyanova-Scholz, M, Babinsky, K, von Hinueber, U, Gromnica-Ihle, E, Wassenberg, S, Antoni, C, Herzer, P, Kekow, J, Schneider, M, Rau, R
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2005
Aiheet:
Extended Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1755655/
https://ncbi.nlm.nih.gov/pubmed/15708884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2004.031476
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia